ES2065894T3 - Empleo de sustancias antigenas para la profilaxis o terapia de los trastornos y enfermedades del aparato digestivo de animales y personas. - Google Patents

Empleo de sustancias antigenas para la profilaxis o terapia de los trastornos y enfermedades del aparato digestivo de animales y personas.

Info

Publication number
ES2065894T3
ES2065894T3 ES88104015T ES88104015T ES2065894T3 ES 2065894 T3 ES2065894 T3 ES 2065894T3 ES 88104015 T ES88104015 T ES 88104015T ES 88104015 T ES88104015 T ES 88104015T ES 2065894 T3 ES2065894 T3 ES 2065894T3
Authority
ES
Spain
Prior art keywords
animals
therapy
diseases
antigen substances
man
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88104015T
Other languages
English (en)
Inventor
Reinhard K Dr Med Ha Teichmann
Walter Prof Dr Med Dr Brendel
Hans-Georg Prof Dr Vet Liebich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mars GmbH
Original Assignee
Effem GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Effem GmbH filed Critical Effem GmbH
Application granted granted Critical
Publication of ES2065894T3 publication Critical patent/ES2065894T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EL INVENTO SE REFIERE A LA APLICACION DE SUSTANCIAS ANTIGENAS PARA PROFILAXE O TERAPIA DE ALTERACIONES Y ENFERMEDADES EN TRATO DIGESTIVO DE ANIMALES Y DEL HOMBRE. ALTERACIONES Y ENFERMEDADES EN TRATO DIGESTIVO DE ANIMALES Y DEL HOMBRE, POR EJEMPLO, DIARREA, ULCERA Y CARZINOME REPRESENTAN EN EL MUNDO ENTERO UN PROBLEMA SERIA, Y SIGNIFICATIVO ECONOMICAMENTE. SE PUEDE DEMOSTRAR, QUE LOS MECANISMOS INMUNOLOGICOS MUESTRAN UN EFECTO PROTECTOR EN TRATOS GASTROINTESTINALES DE ANIMALES Y DEL HOMBRE. LOS ANTIGENOS, QUE CONTIENE LA ALIMENTACION PROVOCAN LOS MECANISMOS PROTECTORES, CUANDO EL ORGANISMO ANTERIORMENTE ESTA SENSIBILIZADO CON ESTOS ANTIGENOS. PREFERIDO ES LA APLICACION DE SUSTANCIAS ANTIGENAS EN LA PROFILAXE Y EN TERAPIA DE ULCERA EN HOMBRE. ADEMAS LAS SUSTANCIAS ANTIGENAS, CONFORME AL INVENTO, SON APROPIADAS PARA LA RECRIA DE GANADEROS JOVENES, QUE EN LA PRIMERA SEMANA DE VIDA EXTRAE POR DEBAJO UNA SUSTITUCION DE FORRAJE.
ES88104015T 1987-04-15 1988-03-14 Empleo de sustancias antigenas para la profilaxis o terapia de los trastornos y enfermedades del aparato digestivo de animales y personas. Expired - Lifetime ES2065894T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873712890 DE3712890A1 (de) 1987-04-15 1987-04-15 Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen

Publications (1)

Publication Number Publication Date
ES2065894T3 true ES2065894T3 (es) 1995-03-01

Family

ID=6325743

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88104015T Expired - Lifetime ES2065894T3 (es) 1987-04-15 1988-03-14 Empleo de sustancias antigenas para la profilaxis o terapia de los trastornos y enfermedades del aparato digestivo de animales y personas.

Country Status (15)

Country Link
EP (1) EP0286847B1 (es)
JP (1) JP2656063B2 (es)
CN (1) CN88102141A (es)
AR (1) AR243384A1 (es)
AT (1) ATE113478T1 (es)
AU (3) AU1370088A (es)
CA (1) CA1325592C (es)
DE (2) DE3712890A1 (es)
DK (1) DK185988A (es)
ES (1) ES2065894T3 (es)
IE (1) IE66559B1 (es)
IL (1) IL85963A (es)
MX (1) MX170929B (es)
NO (1) NO881629L (es)
ZA (1) ZA882504B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US5725861A (en) * 1987-04-15 1998-03-10 Effem Gmbh Products and processes for gastric cascade and gastrointestinal disorder treatment with same
DE3712890A1 (de) * 1987-04-15 1988-10-27 Teichmann Reinhard K Priv Doz Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen
DE3733899A1 (de) * 1987-10-07 1989-06-15 Teichmann Reinhard Prof Dr Med Erzeugnisse und verfahren zur steigerung von wachstumsgeschwindigkeit und/oder nutzung von futter- oder nahrungsmitteln und/oder resistenz bei tieren und menschen
FI902442A7 (fi) * 1988-11-18 1990-05-19 Effem Gmbh Valmisteet ja menetelmät, joilla lisätään eläimillä ja ihmisillä kasvu nopeutta ja/tai ravintoaineiden hyväksikäyttöä ja/tai vastustuskykyä
US6027735A (en) * 1992-07-28 2000-02-22 Effem Gmbh Products and processes for gastric cascade and gastrointestinal disorder treatment with same
CA2373166C (en) 1999-07-28 2009-05-19 Morinaga Milk Industry Co., Ltd. Antiulcer agent
WO2003002135A2 (en) * 2000-02-21 2003-01-09 Andries Philippus Pretorius Herbal composition
CN102229898B (zh) * 2011-05-06 2012-11-14 首都医科大学附属北京友谊医院 用于治疗菌群失调症菌群紊乱症的大肠埃希氏菌、制剂及其制备方法
ITFI20130131A1 (it) * 2013-05-31 2014-12-01 Scapecchi Giorgio Composizione farmaceutica per la prevenzione ed il trattamento di patologie ad eziologia infettiva
CN104777310A (zh) * 2015-01-23 2015-07-15 郑振海 一种肿瘤相关抗体定量检测试剂盒
KR102688761B1 (ko) * 2016-03-03 2024-07-29 호유 가부시키가이샤 대두 알레르기의 항원
CN110551220A (zh) * 2019-08-29 2019-12-10 北京勤邦生物技术有限公司 一种滴滴涕单克隆抗体的制备及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2825619A1 (de) * 1977-06-22 1979-01-11 Sandoz Ag Vakzinen gegen ferkel-colibacillose und verfahren zu ihrer herstellung
FR2408351A1 (fr) * 1977-11-14 1979-06-08 Unilever Nv Procede et composition destines a la lutte contre la coccidiose chez la volaille
EP0059521B1 (en) * 1981-03-03 1985-01-02 Centraal Diergeneeskundig Instituut Water-in-oil emulsion for use in the potentation of the immune system of animals
NZ199866A (en) * 1981-03-09 1984-11-09 Cetus Corp Vaccine for prevention of gastroenteric disease:non-pathogenic strain genetically engineered to comprise genes for adhesin and/or toxoids
DE3132412A1 (de) * 1981-08-17 1983-02-24 Vilas V. Boston Mass. Likhite Antigene mit immunstimulierenden adjuvanzien und ihre verwendung in der immunotherapie
GB2132466B (en) * 1982-12-22 1986-10-15 Impro Products Inc Whey product and method for obtaining same
US4472302A (en) * 1983-03-09 1984-09-18 Merck & Co., Inc. Heat shock process for the isolation of bacterial protein
GB8314645D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Bivalent vaccines
FR2551088B1 (es) * 1983-08-29 1985-12-06 Pasteur Institut
EP0138242A1 (en) * 1983-09-07 1985-04-24 Duphar International Research B.V Method of preparing DNA complementary to the genome of coronaviruses
DE3712890A1 (de) * 1987-04-15 1988-10-27 Teichmann Reinhard K Priv Doz Verwendung antigener substanzen zur prophylaxe oder therapie von stoerungen und krankheiten im verdauungstrakt von tieren und menschen
DE3733899A1 (de) * 1987-10-07 1989-06-15 Teichmann Reinhard Prof Dr Med Erzeugnisse und verfahren zur steigerung von wachstumsgeschwindigkeit und/oder nutzung von futter- oder nahrungsmitteln und/oder resistenz bei tieren und menschen

Also Published As

Publication number Publication date
NO881629L (no) 1988-10-17
CN88102141A (zh) 1988-12-21
DK185988D0 (da) 1988-04-06
AU684824B2 (en) 1998-01-08
JP2656063B2 (ja) 1997-09-24
EP0286847A2 (de) 1988-10-19
AU7595194A (en) 1995-01-05
IE66559B1 (en) 1996-01-24
DE3712890A1 (de) 1988-10-27
MX170929B (es) 1993-09-22
EP0286847A3 (en) 1990-09-05
NO881629D0 (no) 1988-04-14
JPH01268644A (ja) 1989-10-26
AU1284392A (en) 1992-05-14
IL85963A0 (en) 1988-09-30
ATE113478T1 (de) 1994-11-15
AU1370088A (en) 1988-10-20
ZA882504B (en) 1988-10-11
AR243384A1 (es) 1993-08-31
CA1325592C (en) 1993-12-28
EP0286847B1 (de) 1994-11-02
DK185988A (da) 1988-10-16
IE881121L (en) 1988-10-15
IL85963A (en) 1994-06-24
DE3851971D1 (de) 1994-12-08

Similar Documents

Publication Publication Date Title
ES2065894T3 (es) Empleo de sustancias antigenas para la profilaxis o terapia de los trastornos y enfermedades del aparato digestivo de animales y personas.
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
KR930702026A (ko) 자기항원의 경구 투여에 의한 자기면역 질병의 치료
ES2099977T5 (es) Composiciones de liberacion prolongada para tratar enfermedades periodontales.
GR3025502T3 (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals.
DE3165429D1 (en) Device for the phototherapeutical treatment of hyperbilirubenemia
NO943151L (no) Tilstedeværende suppresjon av autoimmune sykdommer
HU9301978D0 (en) Application of complementary inhibitors in medical preparatives used for treatment of inflammatory diseases of intestines and skin
ES2071484T3 (es) Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral.
ES2133322T3 (es) Utilizacion de la proteina l2 para el tratamiento terapeutico de los tumores o lesiones causadas por el papilomavirus.
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
ES2068705T3 (es) Tratamiento de la enfermedad neoplastica con interleuquina-10.
DE69418183D1 (de) Immunotherapeutische zubereitung
KR890700353A (ko) 면역독소의 면역억제 기저 사람치료법
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
ATE111357T1 (de) Synergetische immunostimulierende zusammensetzung und ihre verwendung.
DK137589A (da) Salicylsyreholdigt middel til behandling af hudsygdomme
AR015956A1 (es) Composiciones de citoquinas oromucosales y usos de las mismas
Hart History of the treatment of rheumatoid arthritis
SE8303729D0 (sv) Terapeutiskt medel for behandling av allergiska sjukdomstillstand, immunkomplexsjukdomar och tumorer
ES2053925T3 (es) Una composicion para el tratamiento de pacientes con sindrome de inmunodeficiencia adquirida.
RU93051046A (ru) Способ борьбы с аскосферозом и гнильцовыми болезнями пчел
Lowinger et al. What are the prejudices of the psychiatrist about his patient?
NO953311L (no) Anvendelse av anti-helmint-vaksiner ved kontroll av parasittsykdom i forbindelse med tap av naturlig immunitet
MURINE PSEUDOMONAS AEKÜ6IN0SA TOXOID

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 286847

Country of ref document: ES